Warning: The NCBI web site requires JavaScript to function. more...
Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.
Angyal A, Egelston C, Kobezda T, Olasz K, László A, Glant TT, Mikecz K.
Arthritis Res Ther. 2010;12(2):R44. Epub 2010 Mar 18.
Related citations
T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system.
Bárdos T, Mikecz K, Finnegan A, Zhang J, Glant TT.
J Immunol. 2002 Jun 15;168(12):6013-21.
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
Arthritis Rheum. 2006 Aug;54(8):2423-33.
Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.
Hamel K, Doodes P, Cao Y, Wang Y, Martinson J, Dunn R, Kehry MR, Farkas B, Finnegan A.
J Immunol. 2008 Apr 1;180(7):4994-5003.
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis.
O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A.
J Immunol. 2005 Mar 15;174(6):3781-8.
Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.
Bárdos T, Czipri M, Vermes C, Zhang J, Mikecz K, Glant TT.
Clin Exp Immunol. 2002 Aug;129(2):224-31.
Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation.
Berlo SE, van Kooten PJ, Ten Brink CB, Hauet-Broere F, Oosterwegel MA, Glant TT, Van Eden W, Broeren CP.
J Autoimmun. 2005 Nov;25(3):172-80. Epub 2005 Oct 27.
Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes.
Broere F, Wieten L, Klein Koerkamp EI, van Roon JA, Guichelaar T, Lafeber FP, van Eden W.
J Immunol. 2008 Jul 15;181(2):899-906.
Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis.
Sarraj B, Ludányi K, Glant TT, Finnegan A, Mikecz K.
J Immunol. 2006 Aug 1;177(3):1932-40.
Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
Glant TT, Radacs M, Nagyeri G, Olasz K, Laszlo A, Boldizsar F, Hegyi A, Finnegan A, Mikecz K.
Arthritis Rheum. 2011 May;63(5):1312-21. doi: 10.1002/art.30261.
Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis.
Holló K, Glant TT, Garzó M, Finnegan A, Mikecz K, Buzás E.
Clin Exp Immunol. 2000 Apr;120(1):167-73.
FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M, Brinkmann V, Zerwes HG.
Int Immunopharmacol. 2006 Dec 20;6(13-14):1902-10. Epub 2006 Aug 30.
Development of inflammation in proteoglycan-induced arthritis is dependent on Fc gamma R regulation of the cytokine/chemokine environment.
Kaplan CD, O'Neill SK, Koreny T, Czipri M, Finnegan A.
J Immunol. 2002 Nov 15;169(10):5851-9.
Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis.
O'Neill SK, Cao Y, Hamel KM, Doodes PD, Hutas G, Finnegan A.
J Immunol. 2007 Oct 15;179(8):5109-16.
FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration.
Hwang SJ, Kim JH, Kim HY, Kim S, Chung DH.
Lab Invest. 2010 Jan;90(1):9-19. Epub 2009 Oct 12.
Reduction of CD4 positive T cells and improvement of pathological changes of collagen-induced arthritis by FTY720.
Wang F, Tan W, Guo D, He S.
Eur J Pharmacol. 2007 Nov 14;573(1-3):230-40. Epub 2007 Jul 24.
Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis.
Brennan FR, Mikecz K, Buzás EI, Ragasa D, Cs-Szabó G, Negroiu G, Glant TT.
Clin Exp Immunol. 1995 Sep;101(3):414-21.
A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis.
Abreu JR, Dontje W, Krausz S, de Launay D, van Hennik PB, van Stalborch AM, Ten Klooster JP, Sanders ME, Reedquist KA, Vervoordeldonk MJ, Hordijk PL, Tak PP.
Arthritis Res Ther. 2010;12(1):R2. Epub 2010 Jan 6.
Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis.
Mohan K, Issekutz TB.
J Immunol. 2007 Dec 15;179(12):8463-9.
Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen.
Setoguchi K, Misaki Y, Araki Y, Fujio K, Kawahata K, Kitamura T, Yamamoto K.
J Immunol. 2000 Nov 15;165(10):5980-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on